100
Participants
Start Date
July 17, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
medication review and deprescribing
"The study protocol includes the following assessments:~* T0: first data collection upon admission to the ward;~* T1 assessment: pharmacological review at discharge. Subjects who meet all study eligibility criteria will come consecutively enrolled in the study during admission to the department (T0).~By consulting the electronic health record, interviewing patients and family members and personal documentation, the following data will be collected:~* Remote and immediate pathological history;~* Family and social history;~* Home therapy;~* BRIEF-MPI. Home therapy and therapy suggested at discharge will be compared with the STOPPandSTART criteria to evaluate the prevalence of potential therapies inappropriate and to study possible interactions and contraindications pharmacological and for reporting possible adverse reactions to drugs. The prevalence and possible prevalence of each individual STOPPandSTART criterion will be assessed association with other variables of interest."
Regione del Veneto - AULSS n. 7 Pedemontana, Santorso
Regione del Veneto - AULSS n. 7 Pedemontana
OTHER